Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care.
JCO Oncol Pract. 2024 Mar 5:OP2300601. doi: 10.1200/OP.23.00601. Online ahead of print.
JCO Oncol Pract. 2024.
PMID: 38442324
No abstract available.
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care.
Febbo PG, Allo M, Alme EB, Cuyun Carter G, Dumanois R, Essig A, Kiernan E, Kubler CB, Martin N, Popescu MC, Leiman LC.
Febbo PG, et al. Among authors: dumanois r.
JCO Precis Oncol. 2024 Jan;8:e2300382. doi: 10.1200/PO.23.00382.
JCO Precis Oncol. 2024.
PMID: 38166232
Free PMC article.
Review.
Item in Clipboard
Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data.
Scott JA, Lennerz J, Johnson ML, Gordan LN, Dumanois RH, Quagliata L, Ritterhouse LL, Cappuzzo F, Wang B, Xue M, Vasudevan A, Varughese P, Vaidya V, Gart M, Dorrow N, Gierman HJ, Choksi RJ.
Scott JA, et al. Among authors: dumanois rh.
JCO Oncol Pract. 2024 Jan;20(1):145-153. doi: 10.1200/OP.22.00611. Epub 2023 Aug 9.
JCO Oncol Pract. 2024.
PMID: 37556776
Free PMC article.
Item in Clipboard
Cancer patient management: Current use of next-generation sequencing in the EU TOP4.
Hedblom AH, Pruneri G, Quagliata L, Costa JL, Dumanois R, Rolando C, Saunders R.
Hedblom AH, et al. Among authors: dumanois r.
J Cancer Policy. 2023 Mar;35:100376. doi: 10.1016/j.jcpo.2022.100376. Epub 2022 Nov 26.
J Cancer Policy. 2023.
PMID: 36511325
Free article.
Item in Clipboard
Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer.
Tsimberidou AM, Elkin S, Dumanois R, Pritchard D.
Tsimberidou AM, et al. Among authors: dumanois r.
Clin Lung Cancer. 2020 Nov;21(6):477-481. doi: 10.1016/j.cllc.2020.05.029. Epub 2020 Jun 5.
Clin Lung Cancer. 2020.
PMID: 32718774
Item in Clipboard
The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.
Dormady S, Broder MS, Putcha GV, Dumanois RH, DeCristofaro AH, Chang E, Billings PR, Jahan T.
Dormady S, et al. Among authors: dumanois rh.
Int J Clin Oncol. 2015 Feb;20(1):59-69. doi: 10.1007/s10147-014-0700-8. Epub 2014 Jun 6.
Int J Clin Oncol. 2015.
PMID: 24902933
Item in Clipboard
Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.
Roth JA, Billings P, Ramsey SD, Dumanois R, Carlson JJ.
Roth JA, et al. Among authors: dumanois r.
Oncologist. 2014 May;19(5):466-76. doi: 10.1634/theoncologist.2013-0357. Epub 2014 Apr 7.
Oncologist. 2014.
PMID: 24710309
Free PMC article.
Item in Clipboard
Cite
Cite